Your browser doesn't support javascript.
loading
Result Turnaround Time of RT-PCR for SARS-CoV-2 is the Main Cause of COVID-19 Diagnostic Delay: A Country-Wide Observational Study of Mexico and Colombia.
Núñez, Isaac; Belaunzarán-Zamudio, Pablo F; Caro-Vega, Yanink.
Afiliação
  • Núñez I; Department of Medical Education, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Belaunzarán-Zamudio PF; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Caro-Vega Y; Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Rev Invest Clin ; 74(2): 071-080, 2022 Mar 15.
Article em En | MEDLINE | ID: mdl-35038256
ABSTRACT

BACKGROUND:

Delay in COVID-19 diagnosis due to late real-time reverse transcription-polymerase chain reaction reporting has been described to be an important cause of suboptimal COVID-19 surveillance and outbreak containment.

OBJECTIVE:

The objective of the study was to determine the duration of diagnostic delay due to test turnaround time and its association with marginalization status.

METHODS:

In this observational study using national open data of Mexico and Colombia, we quantified the delay in COVID-19 diagnosis that occurred in both countries. We considered two periods that contributed to the delay in diagnosis the time from symptom onset until testing (delay-one) and test turnaround time (delay-two). Marginalization status was determined according to country-specific scores.

RESULTS:

Among 3,696,773 patients from Mexico and Colombia, delay-two was generally longer than delay-one. Median delay-one was 3 days and delay-two 7 days in Colombia, while in Mexico, they were 3 days and 4 days, respectively. In Colombia, worse marginalization status prolonged delaytwo. In Mexico, a lower number and percentage of rapid tests were performed in areas with worse marginalization.

CONCLUSION:

Diagnostic delay was mostly due to test turnaround time. Marginalization status was an important barrier to diagnostic test access.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Diagnostic_studies / Observational_studies Limite: Humans País como assunto: America do sul / Colombia / Mexico Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Diagnostic_studies / Observational_studies Limite: Humans País como assunto: America do sul / Colombia / Mexico Idioma: En Ano de publicação: 2022 Tipo de documento: Article